Not every prostate cancer needs immediate treatment. For many men with early localised disease, active surveillance is a safe and well-established approach that monitors the cancer closely with PSA tests, MRI scans and, in some cases, repeat biopsy, while delaying or avoiding treatments and their side effects. Active surveillance can offer comparable survival outcomes to treatment while reducing overtreatment.
Active surveillance means monitoring prostate cancer carefully rather than treating it straight away. It is designed for men with small early tumours that unlikely to cause harm in the short to medium term, but who still need structured follow-up so that treatment can be started promptly if the cancer changes. This is not “doing nothing”, it is an active management strategy built around regular review, repeat PSA tests, imaging and clear triggers for intervention.
Active surveillance is usually considered for men with early localised low-risk prostate cancers (i.e. Gleason 3+3 or Cambridge Prognostic Group 1), and in selected cases of intermediate-risk disease (i.e. Gleason 3+4 or Cambridge Prognostic Group 2). Active surveillance may be appealing if you wish to avoid or delay side effects associated with surgery or radiotherapy, are comfortable with ongoing monitoring and understand that treatment may still be needed at a later date.
A typical active surveillance programme includes:
The main benefit of active surveillance is that it can help men avoid or postpone treatment and its side effects without compromising safety in appropriately selected and monitored cases. Advantages include avoiding or delaying urinary incontinence and sexual dysfunction associated with prostate surgery or radiotherapy, preserving quality of life while maintaining a route to treatment if needed, and reducing overtreatment of slow-growing cancers that may never become clinically significant during a patient’s lifetime.
Active surveillance does not mean treatment is ruled out forever. Treatment may be recommended if there is evidence that the cancer is getting worse over time.
Possible triggers for moving from surveillance to treatment include:
If treatment becomes necessary, options may include robotic prostatectomy, radiotherapy or focal therapy depending on the nature and location of the cancer.
These terms are often confused, but they are not the same. Active surveillance is a structured cancer management strategy with the intention of offering curative treatment later if the disease changes, whereas watchful waiting is usually a less intensive approach focused on symptom monitoring in men for whom curative treatment is less likely to be appropriate. For men who are fit and healthy, active surveillance is usually the more relevant option.
Useful questions include:
Get in touch with us today! Our dedicated team is here to assist you with any questions or concerns you may have. We encourage you to reach out to us via email, phone, or by filling out our convenient online form. Your inquiries are important to us, and we look forward to providing you with the support you need.
Schedule a consultation with our specialists and start your health journey today.
Find answers to common questions about our services and appointment process.